Sapient Capital LLC Merck & Co., Inc. Transaction History
Sapient Capital LLC
- $4.51 Trillion
- Q1 2024
A detailed history of Sapient Capital LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Sapient Capital LLC holds 476,221 shares of MRK stock, worth $59.9 Million. This represents 1.4% of its overall portfolio holdings.
Number of Shares
476,221
Previous 483,863
1.58%
Holding current value
$59.9 Million
Previous $53.1 Billion
18.98%
% of portfolio
1.4%
Previous 1.37%
Shares
3 transactions
Others Institutions Holding MRK
# of Institutions
3,770Shares Held
1.87BCall Options Held
17.3MPut Options Held
14.8M-
Vanguard Group Inc Valley Forge, PA243MShares$30.6 Billion0.65% of portfolio
-
Black Rock Inc. New York, NY207MShares$26 Billion0.65% of portfolio
-
State Street Corp Boston, MA117MShares$14.8 Billion0.7% of portfolio
-
Wellington Management Group LLP Boston, MA86.3MShares$10.9 Billion2.07% of portfolio
-
Geode Capital Management, LLC Boston, MA56.4MShares$7.1 Billion0.7% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $319B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...